Galmed Pharmaceuticals (GLMD) Receivables - Other (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Receivables - Other of $451000.0 for Q1 2026, up 0.89% year-over-year from $447000.0 in Q1 2025, and up 29.97% quarter-over-quarter from $347000.0 in Q4 2025.
Galmed Pharmaceuticals (GLMD) Receivables - Other (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Receivables - Other history runs 14 years deep, the most recent figure standing at $451000.0 for Q1 2026.
- In Q1 2026, Receivables - Other rose 0.89% year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $451000.0 (up 0.89% YoY), while the FY2025 annual figure was $347000.0, down 48.36% from the prior year.
- Receivables - Other for Q1 2026 stood at $451000.0, up from $347000.0 in the prior quarter.
- The five-year high for Receivables - Other was $1.2 million in Q3 2022, with the low at $20000.0 in Q4 2024.
- The 5-year median for Receivables - Other is $433000.0 (2025), against an average of $432294.1.
- The sharpest annual moves came in 2022 and 2025: Receivables - Other plunged 97.07% in 2022, then surged 1635.0% in 2025.
- Galmed Pharmaceuticals' Receivables - Other stood at $33000.0 in 2022, then jumped by 1354.55% to $480000.0 in 2023, then tumbled by 95.83% to $20000.0 in 2024, then soared by 1635.0% to $347000.0 in 2025, then climbed by 29.97% to $451000.0 in 2026.
- Business Quant data shows GLMD's Receivables - Other at $451000.0 in Q1 2026, $347000.0 in Q4 2025, and $549000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 451,000.00 |
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Mar 31, 2025 | 447,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 426,000.00 |
| Sep 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 480,000.00 |
| Dec 31, 2023 | 480,000.00 |